Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.

UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid. Mol Cancer Res. 2009 Nov; 7(11):1861-70.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.